Needle-Free Delivery Technology Market Forecast 2015-2025 : Opportunities for Leading Companies

ニードルフリードラッグデリバリー技術の世界市場:ジェット・インジェクター、新規注射針技術、吸入器技術、経皮パッチ技術

◆タイトル:Needle-Free Delivery Technology Market Forecast 2015-2025 : Opportunities for Leading Companies
◆商品コード:VGAIN5052607
◆調査・発行会社:visiongain
◆発行日:2015年5月
◆ページ数:208
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserGBP1,799 ⇒換算¥269,850見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥449,850見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥749,850見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、ニードルフリードラッグデリバリー技術の世界市場について調査・分析し、以下の構成でお届けいたします。

・レポートの概要
・イントロダクション
・ニードルフリードラッグデリバリー技術の世界市場
 (市場規模予測、市場の成長要因・阻害要因など)
・ニードルフリードラッグデリバリー技術の世界市場:セグメント別市場分析
 - ジェット・インジェクター市場
 - 競争技術市場:新規注射針技術、吸入器技術、経皮パッチ技術
・地域別市場分析、市場規模予測
・市場環境分析
・専門家の見解
・主要企業分析
・結論

Needle-Free Delivery Technology – assess products, developments, and revenue prospects
What does the future hold for the needle-free delivery technology market? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 208 page report provides 97 tables, charts, and graphs covering 2 distinct submarket and 3 leading segments. Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcript of five exclusive expert opinion interviews with industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
- Mr Mark Logomasini, Director of Business Development, Bioject Medical Technologies
- Mr David Hoey, CEO, Vaxxas
- Mr Chris Cappello, CTO, PharmaJet
- Dr D F Chowdhury, CEO, Nemaura
- Mr Robert E. Sievers, CEO and President, Aktiv-Dry LLC, and Professor, Department of Chemistry and Biochemistry, Center for Pharmaceutical Biotechnology, University of Colorado, Boulder

You will find prospects for key submarkets
In addition to analyses of the overall world market, you will see revenue forecasting of 2 major submarkets and 3 leading segments to 2025:
• Jet injectors

• Competing technologies
- Novel needle technology
- Inhaler technology
- Transdermal patch technology

Our new study also provides qualitative analyses for each submarket identifying strengths, weaknesses, opportunities and potential threats to sales growth.

How will those needle-free delivery technology markets expand? Which applications will generate most money? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.

What are the prospects in the leading regions and countries?
Events and progress worldwide will influence the market.
In our study you will find individual revenue forecasts to 2025 for the leading regional and national markets:
• US
• Japan
• Germany
• France
• UK
• Spain
• Italy
• India
• China
• RoW


Many opportunities exist within the needle-free delivery technology market. Greater uptake of existing technology and products worldwide will also stimulate the industry and market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints. See what is likely to achieve the most success.

Leading companies and potential for market growth
Overall world revenue for the needle-free delivery technology market will reach $1.2bn in 2015, our work forecasts. We predict strong revenue growth from 2015 to 2025. Our work shows you what organisations hold greatest potential. See profiles of 6 leading companies and others, including these:
• Antares Pharma
• Zogenix
• 3M
• BD
• PharmaJet
• Bioject Medical Technologies

【レポートの目次】

1. Report Overview
1.1 Global Needle-Free Delivery Technology Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Needle-Free Delivery Technology Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Visiongain Reports
1.12 About Visiongain

2. Introduction to Needle-Free Delivery Technology
2.1 What is Needle-Free Delivery Technology?
2.1.1 Needlestick Injury
2.1.1.1 Blood-Borne Pathogens and Needlestick Injury
2.1.1.2 Accidental Needlestick Injury: A Serious Healthcare Problem
2.2 The Needle-Free Delivery Technology Market
2.3 Jet Injectors
2.3.1 Concerns about Multi-use Nozzle Jet injectors (MUNJIs)
2.3.2 Strengths and Weaknesses of Jet Injectors
2.4 Competing Needle-Free Technologies
2.4.1 Novel Needle Technology
2.4.1.1 Pen Needles
2.4.1.2 Microneedles
2.4.1.3 Hollow Microneedles
2.4.1.4 Solid Coated Microneedles
2.4.1.5 Solid Biodegradable Microneedles
2.4.1.6 Solid Uncoated Microneedles
2.4.1.7 Selection of Microneedles
2.4.2 Inhaler Technology
2.4.3 Transdermal Patch Technology
2.5 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
2.5.1 Pain Management
2.5.1.1 Using Needle-Free Injection Devices to Administer Lidocaine
2.5.2 Vaccine Delivery: Improving Immune Response
2.5.2.1 Needle-Free Vaccine Delivery
2.5.2.2 Mass Immunisation
2.5.3 Insulin Delivery for Diabetics
2.5.4 Paediatric Injections
2.5.5 Other Uses for Needle-Free Injection Technology
2.6 Regulation of the Needle-Free Delivery Technology Market
2.6.1 The US Regulation System
2.6.1.1 Combination Products
2.6.1.2 FDA Statement Clamps Down On Delivery of Medications in Non-approved Needle-Free Devices
2.6.2 The European Regulation System
2.6.2.1 Post Marketing Surveillance in the EU

3. Needle-Free Delivery Technology: World Market 2015-2025
3.1 The Needle-Free Delivery Technology Market: Overview
3.2 Needle-Free Delivery Technology Market Segmentation, 2014
3.3 The Needle-Free Delivery Technology Market Forecast, 2015-2025
3.4 How Will Segmental Market Shares Change to 2025?
3.5 Needle-Free Delivery Technology: Market Trends, 2015-2025
3.6 Needle-Free Delivery Technology: Drivers and Restraints 2015-2025

4. Jet Injectors Technology Market, 2015-2025
4.1 The Jet Injectors Market Overview
4.2 Jet Injectors: Market Forecast 2015-2025
4.3 Jet Injector Devices on the Market
4.3.1 Biojector 2000 (Bioject Medical Technologies)
4.3.2 ZetaJet (Bioject Medical Technologies)
4.3.3 Vision (Antares Pharma)
4.3.4 Vibex (Antares Pharma)
4.3.5 Sumavel DosePro (Endo International)
4.3.6 Stratis (PharmaJet)
4.3.7 LectraJet (D’Antonio Consultants International)
4.3.8 AdvantaJet and GentleJet (Activa Brand Products)
4.3.9 Vitajet (Bioject Medical Technologies)
4.3.10 Med-Jet (Medical International Technologies)
4.3.11 J-Tip (National Medical Products)
4.3.12 Injex30 (Injex Pharma)
4.3.13 SQ-Pen, SQ-X and MHP-1 (Bespak)
4.3.14 E-Jet 100 (Eurojet Medical)
4.3.15 Penjet (Penjet Corporation)
4.4 Jet Injectors Development Pipeline
4.4.1 Glide SDI (Glide Pharmaceutical Technologies)
4.4.2 Zeneo (Crossject)
4.4.3 Relday (Zogenix)
4.4.4 Magnetic Injection (Massachusetts Institute of Technology)
4.4.5 Intradermal (ID) Pen (Bioject Medical Technologies)
4.4.6 Iject and Iject R (Bioject Medical Technologies)
4.4.7 Jupiter Jet (Bioject Medical Technologies)

5. Competing Needle-Free Technology Market, 2015-2025
5.1 The Competing Needle-Free Technology Overview
5.2 The Competing Technology: Market Forecast 2015-2025
5.3 How Will Segmental Market Shares Change to 2025?
5.4 Novel Needle Technology Overview
5.5 Novel Needle Technology: Market Forecast, 2015-2025
5.5.1 Leading Novel Needle Technologies
5.5.1.1 Soluvia Microinjection System (BD)
5.5.1.2 Ultra-Fine Nano 4mm Pen Needle (BD)
5.5.1.3 AutoShield Duo Pen Needle (BD)
5.5.1.4 Microstructured Transdermal Systems (3M)
5.5.1.5 ZP Patch Technology (Zosano)
5.5.2 Novel Needle Technology Development Pipeline
5.5.2.1 Microneedle Patch (Georgia Institute of Technology)
5.5.2.2 Micronjet (NanoPass)
5.5.2.3 DebioJect (Debiotech)
5.5.2.4 AdminPen (nanoBioSciences)
5.5.2.5 PKA SoftTouch (PKA SoftTouch Corp)
5.5.2.6 DrugMat and VaxMat (TheraJect)
5.5.2.7 MicroCor (Corium International)
5.5.2.8 Nanopatch (Vaxxas)
5.5.2.9 Nanotopography Enhanced Microneedle Delivery (University of California-San Francisco, Georgia Institute of Technology and Kimberly-Clark)
5.5.2.10 Memspatch and Micro-Patch (Nemaura)
5.5.2.11 Microneedle Patch for Lidocaine Delivering (National University of Singapore)
5.6 Inhaler Technology Overview
5.7 Inhaler Technology: Market Forecast, 2015-2025
5.7.1 Inhaler Products in the Asthma Market
5.7.1.1 Preventer Inhalers
5.7.1.2 Reliever Inhalers
5.7.2 Inhaler Products in the Insulin Market
5.7.2.1 Afrezza (MannKind)
5.7.3 Inhaler Products in the Vaccine Market
5.7.3.1 FluMist Quadrivalent (MedImmune)
5.7.4 Vaccine Inhaler Pipeline
5.8 Transdermal Patch Technology Overview
5.9 Transdermal Patch Technology: Market Forecast, 2015-2025
5.9.1 Selected Transdermal Patch Products
5.9.1.1 Duragesic (Fentanyl, Janssen Pharmaceuticals)
5.9.1.2 Nicoderm CQ (Nicotine, GlaxoSmithKline)
5.9.1.3 Exelon Patch (Rivastigmine, Novartis)
5.9.1.4 Zecuity (Sumatriptan, Teva)
5.9.2 Transdermal Patch Technology Development Pipeline
5.9.2.1 Electronic Transdermal Patch (Rhenovia Pharma)
5.9.2.2 Electroporation-Mediated DNA Drug Delivery (TriGrid, Ichor Medical Systems)
5.9.2.3 Ultrasonic Waveforms (U-Strip, Transdermal Specialties)
5.9.2.4 Prelude SkinPrep System (Echo Therapeutics)
5.10 Other Competing Needle-free delivery Technology in development
5.10.1 Microbubbles Injection (Shibaura Institute of Technology)
5.10.2 Laser Injection (Seoul National University)
5.10.3 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
5.10.4 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)

6. Leading National Markets 2015-2025
6.1 National Breakdown of the World Needle-Free Technology Market
6.2 World Needle-Free Delivery Technology Market: Regional Forecast 2015-2025
6.2.1 How Will Regional Market Shares Change to 2025?
6.3 The US Needle-Free Delivery Technology Market 2015-2025
6.3.1 US Needle-Free Delivery Technology Market Forecast 2015-2025
6.3.2 FDA Guideline for Combination Products
6.3.3 Needle-Free Delivery and the US Flu Vaccination Market
6.3.4 Measles Outbreak in the US
6.4 The EU5 Needle-Free Delivery Technology Market 2015-2025
6.4.1 EU5 Needle-Free Delivery Technology Market Forecast 2015-2025
6.4.2 The German Needle-Free Delivery Technology Market Forecast, 2015-2025
6.4.3 The French Needle-Free Delivery Technology Market Forecast, 2015-2025
6.4.4 The UK Needle-Free Delivery Technology Market Forecast, 2015-2025
6.4.5 The Italian Needle-Free Delivery Technology Market Forecast, 2015-2025
6.4.6 The Spanish Needle-Free Delivery Technology Market Forecast, 2015-2025
6.5 The Japanese Needle-Free Delivery Technology Market 2015-2025
6.5.1 Japanese Needle-Free Delivery Technology Market Forecast 2015-2025
6.6 The Chinese Needle-Free Delivery Technology Market 2015-2025
6.6.1 Chinese Needle-Free Delivery Technology Market Forecast 2015-2025
6.7 The Indian Needle-Free Delivery Technology Market 2015-2025
6.7.1 Indian Needle-Free Delivery Technology Market Forecast 2015-2025
6.7.2 Needles and Syringes Being reused in Indian Hospitals

7. Leading Companies in the Needle-Free Delivery Technology Market
7.1 Leading Needle-Free Delivery Technology Manufacturers in 2014
7.2 Antares Pharma
7.2.1 Antares Pharma: Needle-Free Delivery Technology Product Portfolio
7.2.2 Antares Pharma: Financial Overview
7.2.3 Antares Pharma: Products in Development
7.2.4 Settlement of Patent Infringement Case between Antares Pharma and Medac Pharma
7.3 Zogenix
7.3.1 Zogenix: Product Portfolio
7.3.2 Zogenix: Current Pipeline
7.3.3 Zogenix: Financial Overview
7.4 3M
7.4.1 3M: Needle-Free Delivery Technology Product Portfolio
7.4.1.1 3M: Metered Dose Inhaler
7.4.1.2 3M: Transdermal patch
7.4.1.3 3M: Microneedle
7.4.2 3M: Financial Overview
7.5 BD
7.5.1 BD: Needle-Free Delivery Technology Product Portfolio
7.5.2 BD: Financial Overview
7.5.3 Recall of BD Needles in HongKong
7.6 PharmaJet
7.6.1 PharmaJet: Needle-Free Delivery Technology Product Portfolio
7.6.2 First FDA Approved Jet Injector for Flu Shot in the US
7.6.3 PharmaJet: Collaborations and Needle-Free Delivery Technology Pipeline
7.6.4 Preference for PharmaJet over Needle and Syringe
7.7 Bioject Medical Technologies
7.7.1 Bioject Medical Technologies: Needle-Free Delivery Technology Product Portfolio and Pipeline
7.7.2 Bioject Medical Technologies: Financial Overview
7.7.3 Focusing on Developing Countries

8. Qualitative Analysis of the Needle-Free Delivery Technology Market 2015-2025
8.1 SWOT Analysis of the Needle-Free Delivery Technology Market
8.2 Strengths
8.2.1 Strong Growth in the Biologic Drug Market
8.2.2 Increasing Development in Transdermal Delivery
8.2.3 No Specialist Training Required and No Needlestick Injuries
8.2.4 Eliminating the Cold Chain Problem
8.3 Weaknesses
8.3.1 Healthcare Practitioners are not Familiar with Novel Delivery Systems
8.3.2 Greater Regulatory Scrutiny
8.3.3 Inefficient Manufacturing Processes
8.4 Opportunities
8.4.1 Emerging Economies Offer Significant Growth Opportunities
8.4.2 Mass Immunisation Programmes around the World
8.4.3 Increasing Global Diabetes Population
8.4.4 Shift towards Home Administration Setting
8.4.5 Extending Life Cycle of Drugs
8.5 Threats
8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce
8.5.2 Needle and Syringes with Anti Needlestick Injury Technology
8.5.3 Limited Clinical Data
8.5.4 Medical Device Excise Tax

9. Research Interviews
9.1 Interview with Mark Logomasini, Director of Business Development, Bioject Medical Technologies
9.1.1 The Spring-Powered, Gas-Powered and Battery Powered Jet Injector Markets
9.1.2 Other Competing Needle-Free Delivery Platforms
9.1.3 Regulations Determine Jet Injector Market
9.1.4 Small Needle Free Delivery Companies Requires Large External Capital
9.2 Interview with David Hoey, CEO, Vaxxas
9.2.1 Vaxxas’s Nanopatch Technology
9.2.2 The Advantages of Using Nanopatch Technology in Developed and Developing Markets
9.2.3 The Challenges of Manufacturing Patch Technology
9.2.4 The Future for the Nanopatch Technology
9.3 Interview with Chris Cappello, CTO, PharmaJet
9.3.1 On Current Collaborations
9.3.2 On potential Competitors and the restraint in the market
9.3.3 The Application of Microneedles and transdermal patches is still limited
9.3.4 On Future Growth of the Jet Injector Market
9.4 Interview with John Turanin, Vice President and General Manager, Zogenix Technologies
9.4.1 The Use of Gas Power in Jet Injectors
9.4.2 The Incentives for Drug Companies in Adopting Needle-Free Delivery
9.4.3 Regulating the Needle-Free Delivery Technology Market
9.4.4 Regional Market Forecasts for Jet Injectors
9.4.5 Jet Injectors: Competitive Space and Restraints on the Market
9.5 Interview with Dr D F Chowdhury, CEO, Nemaura
9.5.1 Current Development of Nemaura
9.5.2 Patented Skin Delivery Platforms
9.5.3 Greatest Restraint: Regulatory Barriers
9.5.4 Advantages over Other Technologies
9.5.5 On Future Trends for the Patch and Microneedle Market
9.6 Interview with Robert E. Sievers, CEO and President, Aktiv-Dry LLC, and Professor, Department of Chemistry and Biochemistry, Center for Pharmaceutical Biotechnology, University of Colorado, Boulder
9.6.1 Aktiv-Dry’s PuffHaler
9.6.2 The Benefits of Inhaler Technology
9.6.3 The Competitive Landscape for Measles Inhaler Vaccines
9.6.4 ACTIV DRY’S Collaborations
9.6.5 The Challenges to Introduction Novel Inhaler Technology

10. Conclusions
10.1 The World Needle-Free Technology Market in 2014 and 2015
10.1.1 Current Leading Needle-Free Technology Segments
10.1.2 Notable Needle-Free Technology Companies
10.1.3 Leading Regional Markets
10.2 World Needle-Free Technology Market Forecast 2015-2025
10.3 The Future of the Needle-Free Technology Market?
10.3.1 Biosimilars are a Major Driver of the Needle Free Delivery Market
10.3.2 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market

List of Tables
Table 1.1 Leading National Needle-Free Delivery Technology Market Forecast 2015-2025 ($m, AGR%, CAGR%)
Table 2.1 Classification of Jet Injectors by Method of Propulsion
Table 2.2 Strengths and Weaknesses of the Jet Injector Market
Table 2.3 Pen Needle Technology by Needle Length
Table 2.4 Rationale For Needle-Free Vaccine Delivery
Table 2.5 Examples of Needle-Free Vaccine Delivery Systems, 2015
Table 2.6 Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2015
Table 2.7 FDA Guidance on Regulation of Needle-Free Injectors, 2015
Table 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2014
Table 3.2 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 4.1 The Jet Injectors Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.1 The Competing Needle-Free Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.2 Novel Needle Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.3 Inhaler Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.4 Leading Products in the Asthma Preventer Inhaler Market, 2015
Table 5.5 Leading Products in the Asthma Reliever Inhaler Market, 2015
Table 5.6 Insulin Inhalers Withdrawal from the Market or Pipeline, 2015
Table 5.7 Vaccine Inhalers Currently Under Development, 2015
Table 5.8 Transdermal Patch Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.9 Transdermal Patch Products, 2015
Table 6.1 World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2014 and 2015
Table 6.2 World Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Region, 2014-2025
Table 6.3 US Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.4 EU5 Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.5 German Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.6 French Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.7 UK Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.8 Italian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.9 Spanish Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.10 Japanese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.11 Chinese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 6.12 Indian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025
Table 7.1 Antares Pharma: Overview, 2015
Table 7.2 Antares Pharma: Product Portfolio 2015
Table 7.3 Antares’ Revenue ($m) from Major Customers, 2010-2014
Table 7.4 Antares Pharma: Revenue ($m), AGR (%), CAGR (%), 2010-2014
Table 7.5 Antares Pharma: Products in Development 2015
Table 7.6 Zogenix: Overview, 2015
Table 7.7 Zogenix: Revenue ($m), AGR (%), CAGR (%), 2010-2014
Table 7.8 Zogenix: Revenue ($m) by Type, 2010-2014
Table 7.9 3M: Overview, 2015
Table 7.10 3M: Diabetes Care Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.11 BD: Overview, 2015
Table 7.12 BD: Needle-Free Delivery Technology Product Portfolio 2015
Table 7.13 BD: Revenue ($bn) by Geographic Region, 2012-2014
Table 7.14 BD: Diabetes Care Revenue ($m), AGR (%), CAGR (%), 2009-2014
Table 7.15 PharmaJet: Overview, 2015
Table 7.16 Bioject Medical Technologies: Overview, 2015
Table 7.17 Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
Table 7.18 Bioject Medical Technologies: Revenue ($m), AGR (%), CAGR (%), 2010-2014
Table 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market, 2015-2025
Table 8.2 Average Price For Needle-Free Drug/Vaccine Delivery Technology, 2014

List of Figures
Figure 1.1 Indian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 1.2 Global Needle-Free Delivery Technology Market Segmentation Overview, 2015
Figure 2.1 Percentage (%) of Needlestick Injuries During the Timeline of Use to Disposal of a Device
Figure 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2014-2025
Figure 3.2 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2014
Figure 3.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2019
Figure 3.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2025
Figure 3.5 Needle-Free Delivery Technology: Drivers and Restraints 2015-2025
Figure 4.1 The Jet Injectors Market: Revenue ($m), AGR (%), 2014-2025
Figure 5.1 The Competing Needle-Free Technology Market: Revenue ($m), AGR (%), 2014-2025
Figure 5.2 Market Shares (%) of Competing Needle-Free Technology Market Segments, 2014
Figure 5.3 Market Shares (%) of Competing Needle-Free Technology Market Segments, 2019
Figure 5.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2025
Figure 5.5 Novel Needle Technology Market: Revenue ($m), AGR (%), 2014-2025
Figure 5.6 Inhaler Technology Market: Revenue ($m), AGR (%), 2014-2025
Figure 5.7 Transdermal Patch Technology Market: Revenue ($m), AGR (%), 2014-2025
Figure 6.1 World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2014
Figure 6.2 World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2015
Figure 6.3 World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2014-2025
Figure 6.4 World Needle-Free Delivery Technology Market: Market Shares (%) by Regional Market, 2014
Figure 6.5 World Needle-Free Delivery Technology Market: Market Shares (%) by Regional Market, 2019
Figure 6.6 World Needle-Free Delivery Technology Market: Market Shares (%) by Regional Market, 2025
Figure 6.7 US Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.8 EU5 Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.9 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2014
Figure 6.10 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2019
Figure 6.11 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2025
Figure 6.12 German Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.13 French Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.14 UK Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.15 Italian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.16 Spanish Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.17 Japanese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.18 Chinese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 6.19 Indian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025
Figure 7.1 Antares’ Revenue from Major Customers, 2010-2014
Figure 7.2 Antares Pharma: Revenue ($m), AGR (%), 2010-2014
Figure 7.3 Zogenix: Revenue ($m), AGR (%), 2010-2014
Figure 7.4 Zogenix: Revenue ($m) by Type, 2010-2014
Figure 7.5 3M: Diabetes Care Revenue ($m), AGR (%), 2009-2014
Figure 7.6 BD: Revenue ($bn) by Geographic Region, 2012-2014
Figure 7.7 BD: Diabetes Care Revenue ($m), AGR (%), 2009-2014
Figure 7.8 Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
Figure 7.9 Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
Figure 8.1 The Transport Process For a Vaccine

【掲載企業】

3M
Actavis
Activa Brand Products
AcuShot
Adamis
Aktiv-Dry
Alkermes
Alza
Anesiva
Antares Pharma
Aradigm
Astellas Pharma
AstraZeneca
BD
BeadTek
Berlex Labs
Bespak
bioCSL
Bioject Medical Technologies
Biomedics
Boehringer Ingelheim
Bristol-Myers Squibb and Somerset Pharmaceuticals
Cambridge Consultants
CareFusion Corporation
CEA-LETI
Corium International
CosMed
Crossject
CureVac
D’Antonio Consultants International
Debiotech
Durect
Echo Therapeutics
Elcam Medical
Eli Lilly & Co
Endo International
Ethical Holdings/Schering
Eurojet Medical
Ferndale
Georgia Institute of Technology
Giant Eagle
GlaxoSmithKline
Glide Pharmaceutical Technologies
Hangzhou Hema Medical Equipment
Haselmeir GmbH
Health-Mor Personal Care
Hirtenberger
Ichor
iHealthNet
Immunomic Therapeutics
ImmusanT
Injex Pharma
Invion
Janssen Pharmaceuticals
Key Pharmaceuticals
Kroger
LEO Pharma
LTS Lohmann Therapie-Systeme
MannKind
Mecaplast
Meda Pharmaceuticals
Medac Pharma
Medical International Technologies
Medi-Ject
MedImmune
Merck
Merck Serono
Micron Biomedical
Mylan
nanoBioSciences
NanoPass
Napp Pharmaceuticals
National Medical Products
Nektar Therapeutics
Nemaura
Nicobrand Limited
Novartis
Novo Nordisk
Novogyne Pharmaceuticals
NuPathe
Nycomed
Ortho-McNeil
Owen MumFord Inc
Par Pharmaceutical
Parke-Davis
Penjet Corporation
Pernix
Pfizer
PharmaJet
PKA SoftTouch Corp
Procter & Gamble
ProStrakan
Purdue Pharma
Radius Health
Rhenovia Pharma
Rite Aid
Roche
Sandoz
Sanofi
Searle Pharmaceuticals
Shire
SHL Group AB
Shwarz-Pharma
Société Nationale des Poudres et Explosifs
STADA Arzneimittel AG
Stat Medical Devices
Takeda
Teva
The Medical House
TheraJect
TheraTech
Transdermal Specialties
Trimeris
Trinity-Chiesi
UCB Pharma
University of California-San Francisco
Vaxxas
Vetter Pharma
Vyteris
Watson
West Pharmaceuticals
Westmount Pharmacy
Ypsomed AG
Zogenix
Zosano
Zydus Cadila

【レポートのキーワード】

ニードルフリードラッグデリバリー技術、ジェット・インジェクター、新規注射針技術、吸入器技術、経皮パッチ技術、注射針、注射器、薬物送達、薬剤、薬剤投与

★調査レポート[ニードルフリードラッグデリバリー技術の世界市場:ジェット・インジェクター、新規注射針技術、吸入器技術、経皮パッチ技術] ( Needle-Free Delivery Technology Market Forecast 2015-2025 : Opportunities for Leading Companies / VGAIN5052607) 販売に関する免責事項
[ニードルフリードラッグデリバリー技術の世界市場:ジェット・インジェクター、新規注射針技術、吸入器技術、経皮パッチ技術] ( Needle-Free Delivery Technology Market Forecast 2015-2025 : Opportunities for Leading Companies / VGAIN5052607) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆